Is it possible to make cross-study comparisons of urinary continence rates in patients with overactive bladder?

Authors: Staskin, David R.1; Wein, Alan2

Source: Current Medical Research and Opinion, Volume 21, Number 6, June 2005 , pp. 835-838(4)

Publisher: Informa Healthcare

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Several antimuscarinic agents are available for the treatment of overactive bladder but there are few head-to-head studies to guide physicians in choosing one over another. Here we propose ways in which logical adjustments can be made to account for differences in disease severity and placebo effects when considering continence data to allow estimation of relative effectiveness across studies.

Keywords: ANTIMUSCARINIC THERAPY; CROSS-STUDY COMPARISONS; INCONTINENCE; OVERACTIVE BLADDER; PLACEBO EFFECT

Document Type: Miscellaneous

DOI: 10.1185/0300799005X48393

Affiliations: 1: Department of Urology, New York Presbyterian Hospital, New York, USA 2: Department of Urology, University of Pennsylvania, Philadelphia, PA, USA

Your trusted access to this article has expired.

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$51.50 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A